Wake Forest University Health Sciences — Winston-Salem, North Carolina

Wake Forest University Health Sciences is a clinical research site located in Winston-Salem, North Carolina, United States 27157.

Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Wake Forest University Health Sciences has participated in 1006 clinical trials with 355 currently active.

Therapeutic areas: B Acute Lymphoblastic Leukemia, Gastroparesis, Asthma.

Sponsors: National Cancer Institute (NCI), Johns Hopkins Bloomberg School of Public Health, Milton S. Hershey Medical Center.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Winston-Salem

Browse all research sites in North Carolina · View every site in Winston-Salem

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Wake Forest University Health Sciences?

Wake Forest University Health Sciences has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Wake Forest University Health Sciences conducted?

Wake Forest University Health Sciences has 1006 clinical trials on record, with 355 currently active. Their work covers B Acute Lymphoblastic Leukemia, Gastroparesis, Asthma.

Is Wake Forest University Health Sciences accredited by Crixeo Clinical Trials?

Wake Forest University Health Sciences has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Wake Forest University Health Sciences?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.